KIMADIA Legal Status and Governing Law: A State Company, Not a Regulator

1. Key takeaways

The State Company for Marketing Drugs and Medical Appliances (KIMADIA) is a company, not a regulatory authority. Its own website states, in its original wording, that KIMADIA is a public company founded in 1964, governed by the State Companies Law No. 22 of 1997 (as amended) and the Rules of Procedure No. 1 of 1999, wholly owned by the state, possessing legal personality and financial and administrative independence, operating on economic principles, associated with the Ministry of Health, and headquartered in Baghdad. This means it holds no approval power, and its dealings with companies are contractual acts rather than administrative acts. Chinese-language sources commonly describe it as the Iraqi medical device registration and approval authority; that is the first deviation this volume corrects.

• KIMADIA is a wholly state-owned company founded in 1964, associated with the Ministry of Health.
• Its governing instruments are the State Companies Law No. 22 (1997, as amended) and the Rules of Procedure No. 1 (1999).
• It holds no registration or approval function; its dealings with companies are contractual.
• As a state company executing budget-funded projects it is a contracting entity under Instruction No. 1 of 2025.

2. Legal basis

The instruments below establish KIMADIA’s legal nature and the procurement rules that bind it. Verification status follows the source review.

Source-level note. The KIMADIA website self-description is primary and verified. The originals of the State Companies Law No. 22 (1997) and the Rules of Procedure No. 1 (1999) could not be directly verified in this review; the numbers and years are given consistently by KIMADIA’s own website description, so both are classified as primary but indirectly verified.

Extracts of the operative provisions. The website self-description, in its original English, reads: The state company for drug and medical appliances is a public company founded in 1964, is governed by the general companies law No.22 of 1997 as amended and the rules of procedure NO.1 of 1999… It is an economic unit, self-founded and wholly owned by the state and has moral personality, financial and administrative independence and work according to economic principles, associated with the ministry of health, and its main headquarters in Baghdad. In plain terms: a state company, founded in 1964, governed by the two instruments named above; wholly owned by the state, with legal personality and financial and administrative independence, operating on economic principles, associated with the Ministry of Health, headquartered in Baghdad.

Article 1 of Instruction No. 1 of 2025 (definitions) provides that state companies, when executing projects listed in the investment plan or the current plan funded from the federal general budget or from their own budgets, fall within the instruction’s definition of a contracting entity. This is the primary basis for KIMADIA, as a state company, being directly bound by government procurement rules.

3. Expert insights

The four words state company determine its behavioural logic. A regulatory authority’s dealings with companies are administrative licensing, and the remedies run through administrative review or administrative litigation. KIMADIA’s dealings with companies are procurement, contracting, acceptance and payment, and the remedies run through contract objections, objection-period procedures and the dispute resolution mechanisms agreed in the contract. The award-letter publication and objection period developed in article 39 are the direct product of this logic: they place KIMADIA’s conduct entirely inside contract and tender procedures, not inside administrative procedures.

Separation of regulator and buyer is the institutional default in most markets. In Saudi Arabia the SFDA regulates devices while government procurement is executed by entities such as NUPCO, the two roles sitting in different legal persons; in China the drug regulatory authority handles registration review while hospitals and centralised procurement platforms handle purchasing. Iraq distributes the regulation, procurement and marketing functions across different bodies within the Ministry of Health system, yet Chinese-language sources often let one name, KIMADIA, cover all three functions. GRZAN’s judgement is that this conflation makes companies queue at the wrong window: filing a registration application with KIMADIA while submitting tender documents to the Ministry of Health is the most typical wasted motion in early project stages.

Debunking the claim that KIMADIA is the registration and approval authority for medical devices in Iraq. The website self-description lists its legal nature, governing law, ownership and affiliation, and contains no registration or approval function whatsoever; its listed functions (see article 33) are import and marketing, concluding contracts and commercial agencies, opening warehouses, and approving civil warehouse agents and distribution. The plausible origin of the misreading is that KIMADIA does frequently issue notices to companies — on guarantees, tender documents and clearance arrangements — and outsiders inferred approval from the fact that it sends notices, overlooking that the addressees are bidders, suppliers and Scientific Bureaus and that the notices belong to procurement and performance management, not administrative approval.

A company founded in 1964 and governed by a 1997 company law signals institutional inertia rather than institutional renewal. That a state company established in 1964 remains the core entity of Iraq’s public supply channel for medicines and medical appliances shows how path-dependent the public supply system is. For companies the implication is that KIMADIA’s conduct is driven more by internal rules, cabinet decisions and case-specific announcements than by a searchable statute.

4. Practical recommendations

• In the organisational chart of an Iraq project, GRZAN labels KIMADIA explicitly as a state-owned procurement and marketing entity (contracting entity), listed in a separate column from the registration authority (Registration Department of the Technical Affairs Directorate), to prevent internal confusion.
• Handle every dealing with KIMADIA as contract and tender procedure: on receipt of an award letter, check the platform publication date and start counting the objection period, rather than waiting on an administrative rhythm of awaiting a reply.
• Trace every KIMADIA-related obligation to one of three document classes: cabinet decisions, KIMADIA announcements, and tender documents together with the Government Contracts Implementation Instruction No. 1 (2025) they cite. GRZAN does not accept an unnumbered phrase such as KIMADIA provides as a compliance basis.
• Wherever a document pack says KIMADIA approval or KIMADIA registration certificate, require the Arabic document title and number; if none can be produced, treat it as nonexistent.
• Track the verification progress of the State Companies Law No. 22 (1997) and the Rules of Procedure No. 1 (1999). Practical estimate: gazette originals of the two laws currently need to be obtained through the Ministry of Justice gazette library or paper gazettes (no directly accessible official electronic text was found).

5. Verification checklist

• □ Connect directly to the KIMADIA About Us page and re-check the English self-description, confirming the three figures 1964, 22/1997 and 1/1999 are unchanged.
• □ Search the Ministry of Justice gazette library for the original publication issues of the State Companies Law No. 22 (1997) and the Rules of Procedure No. 1 (1999) to complete primary verified status.
• □ Check the definition of contracting entity in Article 1 of Instruction No. 1 of 2025 and confirm state companies are included.
• □ Review the addressees and legal basis of all KIMADIA website announcements and confirm the functional wording contains no approval-type language.
• □ Check the current ministry name: recent announcements of KIMADIA and the Ministry of Health use the Ministry of Health designation; the former Ministry of Health and Environment name must not be reused.
• □ Re-check whether the official documents cited here have been replaced by later instructions or decisions (verification baseline date: 29 October 2026).

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iraqi market. Our team coordinates local importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com